StockData
Royalty Pharma plc logo

Royalty Pharma plc (RPRX) stock

RPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/3051% above fair value
$67.72−0.95 (-1.38%)

Close on Nov 19, 2026Market cap $38.94BP/E 38.5Yield –

Royalty Pharma free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for Royalty Pharma

Royalty Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Royalty Pharma figures

See a number that looks wrong?